Bausch & Lomb warns again on performance
This article was originally published in Clinica
Ophthalmic company Bausch & Lomb (B&L) has once again warned that its earnings and revenues will be below expected levels. The news comes less than a year after a surprise profit warning prompted the company to carry out a structural review and substantial restructuring (see Clinica No 924, p 9). There was also concern after the company cancelled a presentation at a healthcare conference, according to Reuters.